pomavia POMALIDOMIDE

Introduction to pomavia

Pomavia is a medication primarily used to treat multiple myeloma, a type of blood cancer. Available in tablet form, pomavia helps slow or stop the growth of cancer cells and is often used in combination with other therapies to enhance its effectiveness.

Composition of pomavia

Pomavia contains the active ingredient pomalidomide, which works by modulating the immune system to combat cancer cells. It also reduces the blood supply to these cells, aiding in controlling their growth.

Uses of pomavia

• Treatment of multiple myeloma

Side effects of pomavia

• Common side effects: fatigue, nausea, low blood cell counts
• Serious side effects: severe allergic reactions, blood clots, liver problems

Precautions of pomavia

Pomavia can cause birth defects, so it is crucial to avoid pregnancy while taking it. It is contraindicated in pregnancy and in patients with known hypersensitivity to the drug. Regular monitoring of blood counts is recommended during treatment.

How to Take pomavia

Pomavia is taken orally, with the usual starting dose for adults being 4 mg once daily on days 1 to 21 of a 28-day cycle. It should be swallowed whole, with or without food. Always follow your doctor’s advice for the correct usage.

Conclusion of pomavia

Pomavia, containing the active ingredient pomalidomide, belongs to the therapeutic class of immunomodulatory agents. It is primarily used for treating multiple myeloma and is manufactured by leading pharmaceutical companies. Key highlights include its effectiveness in slowing cancer cell growth and the importance of adhering to safety precautions. Pomavia is a critical component in the management of multiple myeloma, offering hope to many patients.